Trial intelligence / Profile preview

Dexmedetomidine in Rhinoplasty

IRCT20211225053519N3Phase 3Completed

Sponsor
Tehran University of Medical Sciences
Start
Oct 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of dexmedetomidine in postoperative pain, sponsored by Tehran University of Medical Sciences. Started Oct 2023; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on IRCT20211225053519N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20211225053519N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call